Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Exelixis, Inc. | EX9 | Nov 25, 2024 | 33.72 | +2.34 |
Exelon Corporation | PEO | Nov 25, 2024 | 36.81 | -1.55 |
ExlService Holdings, Inc. | LHV | Nov 25, 2024 | 44.82 | +1.17 |
Exmar NV | 1EX | Nov 25, 2024 | 8.15 | +4.35 |
Exor N.V. | EYX | Nov 25, 2024 | 95.55 | +1.16 |
EXOSENS EO -,425 | H8Y | Nov 25, 2024 | 20.05 | -0.25 |
eXp World Holdings, Inc. | 44Y | Nov 25, 2024 | 13.35 | +6.21 |
Expedia Group, Inc. | E3X1 | Nov 25, 2024 | 175.58 | -0.84 |
Expeditors International of Washington, Inc. | EW1 | Nov 25, 2024 | 114.40 | +0.22 |
Experian PLC | J2B | Nov 25, 2024 | 46.00 | +2.68 |
Experian Plc | J2BA | Nov 25, 2024 | 45.80 | +2.69 |
EXPERT SYSTEM S P A AZIONI ORDINARIE SENZA VALORE (NOMINALE | 3K2 | Nov 25, 2024 | 1.37 | +0.44 |
Exploits Discovery Corp | 634 | Nov 25, 2024 | 0.03 | +5.07 |
Exponent, Inc. | EP5 | Nov 25, 2024 | 95.00 | +1.41 |
ExpreS2ion Biotech Holding | 5JD0 | Nov 25, 2024 | 1.66 | 0.00 |
ExpreS2ion Biotech Holding | 5JD | Nov 25, 2024 | 0.07 | 0.00 |
Exro Technologies Inc | 1O2 | Nov 25, 2024 | 0.10 | +3.56 |
Exsitec | 1TI | Nov 25, 2024 | 12.25 | -0.41 |
Extendicare Inc | 5XE | Nov 25, 2024 | 6.90 | +0.73 |
Extra Space Storage Inc. | FG8 | Nov 25, 2024 | 162.25 | +0.75 |
Extreme Networks, Inc. | EXM | Nov 25, 2024 | 15.10 | +2.27 |
Exxaro Resources Ltd | LCQ | Nov 25, 2024 | 8.75 | -1.13 |
EXXON MOBIL CDR REG.S | XON | Nov 25, 2024 | 15.01 | 0.00 |
Exxon Mobil Corporation | XONA | Nov 25, 2024 | 114.66 | -2.63 |
EyePoint Pharmaceuticals, Inc. | PV3B | Nov 25, 2024 | 8.67 | +8.27 |
Ezaki Glico Co. Ltd. | 5EJ | Nov 25, 2024 | 25.80 | -1.53 |
EZCORP, Inc. - Class A Non-Voting | EZ2A | Nov 25, 2024 | 12.00 | +4.35 |
F Ramada-Investimentos SGPS S A | Y4E | Nov 25, 2024 | 7.00 | +0.29 |
F+C INVESTMENT TR LS-,25 | 0XW | 0.00 | 0.00 | |
F-Secure Corp | 3I6 | Nov 25, 2024 | 1.81 | +2.03 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.